Pages that link to "Q53213466"
Jump to navigation
Jump to search
The following pages link to Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. (Q53213466):
Displaying 50 items.
- The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events (Q26781635) (← links)
- Clearance systems in the brain-implications for Alzheimer disease (Q26801541) (← links)
- Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice (Q27312360) (← links)
- Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins (Q28189235) (← links)
- Tau-mediated synaptic damage in Alzheimer's disease (Q28831067) (← links)
- How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies (Q30599020) (← links)
- Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice (Q31735508) (← links)
- MEG Beamformer-Based Reconstructions of Functional Networks in Mild Cognitive Impairment (Q33600113) (← links)
- Inhibition of AMPA receptor trafficking at hippocampal synapses by beta-amyloid oligomers: the mitochondrial contribution (Q33784921) (← links)
- Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization (Q34142269) (← links)
- Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats (Q34211231) (← links)
- Cigarette smoking accelerated brain aging and induced pre-Alzheimer-like neuropathology in rats (Q34273687) (← links)
- SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease (Q34620335) (← links)
- Synapse loss in dementias (Q34748678) (← links)
- Pharmacotherapy for Alzheimer's disease: progress and prospects (Q34866800) (← links)
- Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies (Q35231770) (← links)
- Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies (Q35570834) (← links)
- Herbal formula GAPT prevents beta amyloid deposition induced Ca(2+)/Calmodulin-dependent protein kinase II and Ca(2+)/Calmodulin-dependent protein phosphatase 2B imbalance in APPV717I mice (Q36035084) (← links)
- Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease (Q36276592) (← links)
- Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease (Q36402008) (← links)
- Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease (Q36412490) (← links)
- A combination extract of ginseng, epimedium, polygala, and tuber curcumae increases synaptophysin expression in APPV717I transgenic mice (Q36430458) (← links)
- Increased CSF neurogranin concentration is specific to Alzheimer disease (Q36691986) (← links)
- Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease (Q36885492) (← links)
- The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease (Q37169136) (← links)
- The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease (Q37307728) (← links)
- Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability (Q37326829) (← links)
- Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer's disease (Q37568914) (← links)
- Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice (Q38825497) (← links)
- Protection of curcumin against amyloid-β-induced cell damage and death involves the prevention from NMDA receptor-mediated intracellular Ca2+ elevation. (Q38866324) (← links)
- Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer's disease (Q38873321) (← links)
- Chitooligosaccharides attenuate Cu2+-induced cellular oxidative damage and cell apoptosis involving Nrf2 activation. (Q38925285) (← links)
- ApoE and SNAP-25 Polymorphisms Predict the Outcome of Multidimensional Stimulation Therapy Rehabilitation in Alzheimer's Disease. (Q39853087) (← links)
- Truncated tau deregulates synaptic markers in rat model for human tauopathy. (Q41257772) (← links)
- Proposals for re-evaluation of current autopsy criteria for the diagnosis of Alzheimer's disease (Q41612730) (← links)
- Synaptophysin depletion and intraneuronal Aβ in organotypic hippocampal slice cultures from huAPP transgenic mice (Q41841473) (← links)
- Intracellular deposition, microtubule destabilization, and transport failure: an "early" pathogenic cascade leading to synaptic decline (Q41917203) (← links)
- Targeting synaptic pathology with a novel affinity mass spectrometry approach (Q42262870) (← links)
- Hypoglycemic brain injury: potentiation from respiratory depression and injury aggravation from hyperglycemic treatment overshoots (Q42481639) (← links)
- The degree of certainty in brain death: probability in clinical and Islamic legal discourse (Q42595993) (← links)
- Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study (Q42912092) (← links)
- APOE polymorphism and clinical duration determine regional neuropathology in Swedish APP(670, 671) mutation carriers: implications for late-onset Alzheimer's disease. (Q43982514) (← links)
- Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine (Q44188025) (← links)
- Increased phosphorylation of tau and synaptic protein loss in the aged transgenic mice expressing familiar Alzheimer's disease-linked presenilin 1 mutation (Q44546858) (← links)
- CHF5074 restores visual memory ability and pre-synaptic cortical acetylcholine release in pre-plaque Tg2576 mice. (Q45912487) (← links)
- Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers (Q46490492) (← links)
- Proteomics in the Diagnosis of Inborn Encephalopathies of Unknown Origin: A Myth or Reality (Q47688592) (← links)
- Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach (Q47869899) (← links)
- Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update (Q47932570) (← links)
- Premature death in transgenic mice that overexpress a mutant amyloid precursor protein is preceded by severe neurodegeneration and apoptosis (Q48172460) (← links)